An observational study in Crohns Disease, Ulcerative Colitis and Irritable Bowel Syndrome, sponsored by Universität Duisburg-Essen. Status unknown at 1 site in Germany. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2018-05-02.
Sponsored by Universität Duisburg-Essen · Observational
This study aims to test, if a two-week integrative therapy in an internal medicine ward will improve symptoms, disability and quality of life in patients with inflammatory bowel disease or irritable bowel syndrome.a It shall further be tested, if those changes are associated with attitudes and experiences towards complementary and alternative medicine, anxiety, depression and stress perception as well as body awareness and responsiveness.
see above
1,880 studies on the registry are indexed under Crohn Disease; 462 are open to participants now.
This study's planned enrollment of 200 is above the median of 162 across 608 observational studies indexed under Crohn Disease.
Browse Crohn Disease studies →Universität Duisburg-Essen is the lead sponsor of 82 studies on the registry; 13 are open to participants now.
Counted across the registry records on this site, refreshed daily.
100 patients with Inflammentory Bowel Disease admitted to the Department of Internal and Integrative Medicine.
100 patients with Irritable Bowel Syndrome admitted to the Department of Internal and Integrative Medicine.
Exclusion Criteria:
This group receives and integrative therapy at the Department of Internal and Integrative Medicine, i.e. a combination of conventional diagnostic and therapeutic interventions with specific naturopathic, and complementary medicine approaches, and physical therapy. Patients are admitted to the hospital ward for 14 days.
Other: Integrative Therapy
This group receives an integrative therapy at the Department of Internal and Integrative Medicine, i.e. a combination of conventional diagnostic and therapeutic interventions with specific naturopathic, and complementary medicine approaches, and physical therapy.
Symptoms Severity IBS-SSS
Symptoms Severity assessed by Irritable Bowel Syndrome Symptom Severity Score (IBS-SSS) (Francis, 1997)
Time frame: 2 weeks
Symptoms Severity CAI
Symptoms Severity assessed by Clinical Activity Index (CAI) (Rachmilewitz 1989)
Time frame: 2 weeks
Symptoms Severity CDAI
Symptoms Severity assessed by Crohn Disease Activity Index (CDAI)
Time frame: 2 weeks
Symptoms Severity IBS-SSS
Symptoms Severity assessed by Irritable Bowel Syndrome Symptom Severity Score (IBS-SSS) (Francis, 1997)
Time frame: 24 weeks
Symptoms Severity CAI
Symptoms Severity assessed by Clinical Activity Index (CAI) (Rachmilewitz 1989)
Time frame: 24 weeks
Symptoms Severity CDAI
Symptoms Severity assessed by Crohn Disease Activity Index (CDAI)
Time frame: 24 weeks
Disability MYMOP
Disability assessed by Measure Yourself Medical Outcome Profile (MYMOP) (Paterson 1996)
Time frame: 2 weeks
Disability MYMOP
Disability assessed by Measure Yourself Medical Outcome Profile (MYMOP) (Paterson 1996)
Time frame: 24 weeks
Quality of Life IBS-QOL
Irritable Bowel Syndrome Quality of Life measurement (IBS-QOL) (Patrick, 1998)
Time frame: 2 weeks
Quality of Life IBS-QOL
Irritable Bowel Syndrome Quality of Life measurement (IBS-QOL) (Patrick, 1998)
Time frame: 24 weeks
Quality of Life IBDQ
Inflammatory Bowel Disease Questionnaire (IBDQ) (Cooney et al., 2007)
Time frame: 2 weeks
Quality of Life IBDQ
Inflammatory Bowel Disease Questionnaire (IBDQ) (Cooney et al., 2007)
Time frame: 24 weeks
Self efficacy questionnaire SWE
Self efficacy questionnaire (SWE) (Schwarzer and Jerusalem, 1995)
Time frame: 2 weeks
Self efficacy questionnaire SWE
Self efficacy questionnaire (SWE) (Schwarzer and Jerusalem, 1995)
Time frame: 24 weeks
Body awareness BAQ
Body awareness assessed by Body Awareness Questionnaire (BAQ) (Shields et al., 1989)
Time frame: 24 weeks
Body awareness BRS
Body awareness assessed by Body Responsiveness Scale (BRS) (Daubenmier, 2005)
Time frame: 24 weeks
Adverse effects
Number of participants with any adverse effect during the study period
Time frame: 2 weeks
This study is status unknown, as verified in Apr 2018. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Universität Duisburg-Essen